Pandemic-related disruptions in cancer screening showed an uneven recovery in 2023, data from the National Health Interview ...

Researchers examined screening rates for three kinds of cancer before, during, and after the COVID-19 pandemic.

Despite a proven survival benefit, the addition of pembrolizumab (Keytruda) to chemoradiotherapy for newly diagnosed locally ...

From 2008 to 2022, rates for precancerous lesions decreased about 80 percent among 20- to 24-year-old women who were screened ...

A new CDC report finds that rates of precancerous lesions detected in women ages 20 to 24 have decreased by nearly 80%, ...

A new study finds that rates of cervical cancer screenings remain low across the US. House censures Al Green for heckling ...

Breast and colon cancer screening numbers have since rebounded and have even surpassed pre-pandemic screening estimates, a ...

A recent CDC report further demonstrates the effectiveness of the HPV vaccine against cervical cancer. HPV is a sexually ...

Bandi and her team found that past-year cervical cancer screenings in 2023 remained at 14%, which is below pre-pandemic ...

From 2008 to 2022, the incidence of cervical precancers fell by 80% among screened women aged 20 to 24 years, supporting ...

Four of the country’s leading health organisations have come together as part of an Australian Government-funded campaign to ...

Preventive screenings for cancer declined during the pandemic, with lockdowns, social distancing and COVID-19 surges ...